WU Li-ya

961 total citations · 1 hit paper
8 papers, 670 citations indexed

About

WU Li-ya is a scholar working on Surgery, Nutrition and Dietetics and Ecology. According to data from OpenAlex, WU Li-ya has authored 8 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Nutrition and Dietetics and 2 papers in Ecology. Recurrent topics in WU Li-ya's work include Lipoproteins and Cardiovascular Health (3 papers), Nuts composition and effects (3 papers) and Agriculture Sustainability and Environmental Impact (2 papers). WU Li-ya is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Nuts composition and effects (3 papers) and Agriculture Sustainability and Environmental Impact (2 papers). WU Li-ya collaborates with scholars based in Germany, United States and Netherlands. WU Li-ya's co-authors include Klaus G. Parhofer, Elisa Waldmann, Renée Stark, Katharina Lechner, Sandra E. Fischer, Christos S. Mantzoros, John S. Millar, Hans Jansen, Daniel A. Gipe and G. Kees Hovingh and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

WU Li-ya

8 papers receiving 660 citations

Hit Papers

Diabetic dyslipidemia 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WU Li-ya Germany 6 264 175 171 137 119 8 670
Paola Cipriano Italy 17 344 1.3× 139 0.8× 230 1.3× 126 0.9× 85 0.7× 40 874
G. Ferns United Kingdom 16 349 1.3× 252 1.4× 145 0.8× 136 1.0× 186 1.6× 40 975
T. T. Nguyen United States 8 349 1.3× 202 1.2× 68 0.4× 70 0.5× 110 0.9× 10 603
Maire Rantala Finland 13 167 0.6× 192 1.1× 71 0.4× 78 0.6× 113 0.9× 15 640
T. A. Barringer United States 11 109 0.4× 210 1.2× 389 2.3× 104 0.8× 167 1.4× 20 858
Anna Mangione Italy 10 284 1.1× 94 0.5× 112 0.7× 113 0.8× 60 0.5× 11 658
Dimple Aggarwal United States 7 105 0.4× 122 0.7× 90 0.5× 108 0.8× 34 0.3× 12 565
Fernando Lopez‐Segura Spain 18 264 1.0× 366 2.1× 359 2.1× 144 1.1× 150 1.3× 26 1.1k
Yu. I. Ragino Russia 11 86 0.3× 119 0.7× 83 0.5× 156 1.1× 140 1.2× 164 668
Chesney K. Richter United States 14 163 0.6× 144 0.8× 509 3.0× 173 1.3× 97 0.8× 21 1.1k

Countries citing papers authored by WU Li-ya

Since Specialization
Citations

This map shows the geographic impact of WU Li-ya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WU Li-ya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WU Li-ya more than expected).

Fields of papers citing papers by WU Li-ya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WU Li-ya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WU Li-ya. The network helps show where WU Li-ya may publish in the future.

Co-authorship network of co-authors of WU Li-ya

This figure shows the co-authorship network connecting the top 25 collaborators of WU Li-ya. A scholar is included among the top collaborators of WU Li-ya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WU Li-ya. WU Li-ya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Waldmann, Elisa, et al.. (2022). Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia). PLoS ONE. 17(3). e0265838–e0265838. 9 indexed citations
2.
Reeskamp, Laurens F., John S. Millar, WU Li-ya, et al.. (2021). ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 41(5). 1753–1759. 67 indexed citations
3.
Lechner, Katharina, WU Li-ya, Elisa Waldmann, et al.. (2018). A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. Nutrients. 10(2). 244–244. 101 indexed citations
5.
Li-ya, WU, et al.. (2017). THE EFFECT OF PCSK9 INHIBITION ON LDL-SUBFRACTIONS IN PATIENTS WITH SEVERE LDL-HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 69(11). 1719–1719. 4 indexed citations
6.
Li-ya, WU & Klaus G. Parhofer. (2014). Diabetic dyslipidemia. Metabolism. 63(12). 1469–1479. 363 indexed citations breakdown →
7.
Li-ya, WU, Elisa Waldmann, Uli C. Broedl, et al.. (2013). Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: A randomized controlled cross-over clinical trial. Metabolism. 63(3). 382–391. 70 indexed citations
8.
Li-ya, WU. (2010). Antihypertensive Effects of Roots of Apium graveolens Extract in Renal Hypertensive Rats. Zhongguo shiyan fangjixue zazhi. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026